Armenia is working with the Russian Direct Investment Fund (RDIF) to secure vaccine platform technology for the production of Russia's single-dose Sputnik Light coronavirus vaccine, Armenian Deputy Prime Minister Mher Grigoryan revealed on Monday
YEREVAN (Pakistan Point News / Sputnik - 20th September, 2021) Armenia is working with the Russian Direct Investment Fund (RDIF) to secure vaccine platform technology for the production of Russia's single-dose Sputnik Light coronavirus vaccine, Armenian Deputy Prime Minister Mher Grigoryan revealed on Monday.
Yerevan already approved the use of Sputnik Light earlier in September.
"Several batches of the Sputnik V vaccine have been procured, as well as the process of technology transfer for producing the Sputnik Light vaccine has been organized through the RDIF," Grigoryan told a roundtable at the Armenian business Forum.
The Russian single-dose vaccine is currently used on a standalone basis, as well as is studied in combination with other vaccines. RDIF, in particular, has suggested using Sputnik Light as a booster for two-shot AstraZeneca, Moderna and Pfizer coronavirus vaccines. The studies are currently ongoing in Argentina and the UAE.
